aflibercept vs ketorolac ophthalmic
Side-by-side comparison of aflibercept and ketorolac ophthalmic Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Eylea
Acular
AHZANTIVE is a medicine used to treat certain eye problems. It helps to stop blood vessels from growing and leaking in the eye.
Acular LS eye drops help reduce pain, burning, and stinging in your eyes after surgery to correct your vision. It is a nonsteroidal anti-inflammatory drug (NSAID).
AHZANTIVE treats wet age-related macular degeneration (AMD). It also treats swelling in the macula (the central part of the retina) caused by retinal vein occlusion (RVO) or diabetic macular edema (DME). Additionally, it can treat diabetic retinopathy (DR), an eye disease caused by diabetes.
Acular LS eye drops treat pain, burning, and stinging in the eye. You can use it after corneal refractive surgery. This medicine is a nonsteroidal anti-inflammatory drug (NSAID).
AHZANTIVE is a VEGF inhibitor. VEGF is a protein that promotes the growth of new blood vessels. By blocking VEGF, AHZANTIVE helps to reduce the growth of abnormal blood vessels in the eye and decrease leakage.
Acular LS is an NSAID that reduces substances in the body that cause pain and inflammation. It blocks the production of prostaglandins. Prostaglandins cause pain and swelling.
- • Bleeding in the eye
- • Eye pain
- • Clouding of the lens of the eye (cataract)
- • Separation of the vitreous gel from the retina
- • Spots in your vision
- • Eye redness
- • Corneal infiltrates
- • Headache
- • Swelling of the eye
- • Eye pain
- Death 7,853
- Trouble seeing 2,013
- Using the medicine for something it's not approved for 1,509
- Loss of sight 1,459
- Eye infection 1,372
No adverse event reports.
Injections with AHZANTIVE may cause serious eye infections (endophthalmitis), separation of the retina (retinal detachment), and inflammation of blood vessels in the retina. Tell your doctor right away if you have any signs of these problems. AHZANTIVE may also increase the risk of blood clots that can cause stroke or heart attack.
Acular LS may slow or delay healing. Be careful if you are sensitive to aspirin or other NSAIDs. Acular LS may increase bleeding time. Using NSAIDs like Acular LS may cause cornea problems. If you have issues with the cornea, stop using the drops and see your doctor.
It is not known if AHZANTIVE can harm an unborn baby. AHZANTIVE should be used during pregnancy only if the benefit justifies the risk. It is also not known if AHZANTIVE passes into breast milk.
It is not known if Acular LS will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if Acular LS passes into breast milk. Talk to your doctor if you are breastfeeding.
Also Compare — Nearby Drugs
Compare aflibercept with
How to Read This aflibercept vs ketorolac ophthalmic Comparison
aflibercept is classified in the Anti-VEGF (Ophthalmic Injection) drug class, while ketorolac ophthalmic sits within the NSAID (Ophthalmic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aflibercept has 14,206 submissions while ketorolac ophthalmic has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aflibercept and ketorolac ophthalmic — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.